Form 13-F position report

ORAMED PHARMACEUTICALS INC

Reported by THE BANK OF NEW YORK MELLON CORPORATION

ORMP CUSIP 68403P203 Manager CIK 0001390777

First reported at 79,255 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q2 2026
Shares 79,255 Quarter-end amount reported
Reported value $381,217 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1170000
2022-03-31 841000
2022-06-30 0
2026-06-30 381217
2026-09-30 370121

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for ORAMED PHARMACEUTICALS INC held by THE BANK OF NEW YORK MELLON CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 79,255 0 (0.0%) < 0.01% $370,121 2026-11-05
Q2 2026 New 79,255 +79,255 (0.0%) < 0.01% $381,217 2026-08-06
Q2 2022 Reduced 0 -97,214 (-100.0%) 0 $0 2022-08-15
Q1 2022 Added 97,214 +15,296 (18.7%) < 0.01% $841,000 2022-05-11
Q4 2021 Added 81,918 +11,772 (16.8%) < 0.01% $1,170,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

93 managers reported ORAMED PHARMACEUTICALS INC for Q2 2026.

Managers reporting ORAMED PHARMACEUTICALS INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MERCER GLOBAL ADVISORS INC ADV Added 3,810,540 +1,900,000 0.02% $18,328,697 2 qtrs
Aquamarine Financial Cayman Ltd Added 2,512,175 +399,863 0.67% $12,083,562 4 qtrs
Gem Investment Advisors LLC Added 1,998,802 +358,733 5.89% $9,614,238 3 qtrs
BlackRock Inc Added 1,608,111 +1,515,919 < 0.01% $7,735,015 8 qtrs
Murchinson Ltd Reduced 1,290,294 -25,000 0.86% $6,206,314 11 qtrs
BML Capital Management LLC Reduced 866,269 -2,300,962 2.37% $4,166,754 14 qtrs
BOOTHBAY FUND MANAGEMENT LLC Reduced 578,638 -22,078 0.04% $2,783,249 11 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 500,690 +476,408 < 0.01% $2,408,318 29 qtrs
The Goldman Sachs Group Inc New 253,293 +253,293 < 0.01% $1,218,339 1 qtr
STATE STREET CORPORATION New 242,100 +242,100 < 0.01% $1,164,501 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 06, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
68,076
Shared
0
None
11,179

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.